Avandia

Lea en español

AvandiaAvandia (the trade name for Rosiglitazone, marketed by GlaxoSmithKline (GSK)), is a drug approved in 1999 for treatment of type 2 diabetes. The product was used extensively until 2007, when a report in the New England Journal of Medicine linked it with studies showing an increased risk of heart attack. The patent on the drug expired in 2012.
In addition to heart disease, Avandia has been linked to numerous other health concerns, including:

  • Increased risk of stroke
  • Greater susceptibility to bone fractures
  • Excessive weight gain
  • Loss of vision and other eye disease
  • Low blood sugar
  • Moderate to acute hepatitis

There’s evidence that GSK knew of the heart attack risks and covered up what they knew. There’s also evidence that the company threatened researchers who reported any adverse health effects tied to the drug.

If you or someone you love has suffered injury after taking Avandia, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.

Defective Drugs & Medical Devices Topics

Latest Articles

Four Things to Know About Traffic Stops

  You’re driving down the road; you glance down at the speedometer and see that you’re driv…

11 Dec 2018, Tuesday

Small Claims Court: An Overview

  Let’s say that you have a dispute with your landlord. You were asked to pay a security depo…

10 Dec 2018, Monday

Divorce and Taxes

  If you are facing a divorce, you know that there are plenty of difficult, even painful questi…

07 Dec 2018, Friday